A detailed history of Nuveen, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Nuveen, LLC holds 6,343,476 shares of DXCM stock, worth $368 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,343,476
Previous 7,568,890 16.19%
Holding current value
$368 Million
Previous $661 Million 35.39%
% of portfolio
0.12%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$66.46 - $89.53 $81.4 Million - $110 Million
-1,225,414 Reduced 16.19%
6,343,476 $427 Million
Q2 2025

Aug 12, 2025

SELL
$59.83 - $87.57 $33.3 Million - $48.7 Million
-556,646 Reduced 6.85%
7,568,890 $661 Million
Q1 2025

May 12, 2025

BUY
$67.74 - $90.75 $550 Million - $737 Million
8,125,536 New
8,125,536 $555 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.